Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells

Cancer Gene Therapy volume 24, pages 393–400 (2017)Cite this article

Subjects

Abstract

Herpes simplex virus type 1 (HSV-1) is one of the most widely studied viruses for oncolytic virotherapy. In squamous cell carcinoma (SCC) cells, the role of autophagy induced by neurovirulence gene-deficient HSV-1s in programmed cell death has not yet been elucidated. The oncolytic HSV-1 strain RH2, which lacks the γ34.5 gene and induces the fusion of human SCC cells, was used. RH2 replicated and induced cell death in SCC cells. RH2 infection was accompanied by the aggregation of microtubule-associated protein 1 light chain 3 (LC3) in the cytoplasm, the conversion of LC3-I to LC3-II and the formation of double-membrane vacuoles containing cell contents. No significant changes were observed in the expression of Bcl-2 or Bax, while a slight decrease was observed in that of Beclin 1. The autophagy inhibitors, 3-methyladenine (3-MA) and bafilomycin A1, did not affect viral replication, but significantly inhibited the cytotoxicity of RH2. The caspase-3 inhibitor z-DEVD-fmk and caspase-1 inhibitor z-YVAD-fmk also reduced the cytotoxicity of RH2. These results demonstrated that γ34.5 gene-deficient HSV-1 RH2 induced autophagic cell death in SCC cells as well as pyroptosis and apoptosis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  1. Buijs PR, Verhagen JH, van Eijck CH, van den Hoogen BG . Oncolytic viruses: from bench to bedside with a focus on safety. Hum Vaccine Immunother 2015; 11: 1573–1584.

    Article  Google Scholar 

  2. Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE . Oncolytic viruses in cancer therapy. Cancer Lett 2007; 254: 178–216.

    Article  Google Scholar 

  3. Russell SJ, Peng KW, Bell JC . Oncolytic virotherapy. Nat Biotechnol 2012; 30: 658–670.

    Article  CAS  Google Scholar 

  4. Harrington KJ, Hingorani M, Tanay MA, Hickey J, Bhide SA, Clarke PM et al. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck. Clin Cancer Res 2010; 16: 4005–4015.

    Article  CAS  Google Scholar 

  5. Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 2015; 33: 2780–2788.

    Article  CAS  Google Scholar 

  6. Yura Y, Hamada M . Development of oncolytic virothearpy for the treatment of oral cancer -At the waiting stage for clinical use. Oral Sci Int 2017; 14: 1–12.

    Article  Google Scholar 

  7. Pol J, Kroemer G, Galluzzi L . First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology 2015; 5: e1115641.

    Article  Google Scholar 

  8. Kroemer G, Mariño G, Levine B . Autophagy and the integrated stress response. Mol Cell 2010; 40: 280–293.

    Article  CAS  Google Scholar 

  9. Mizushima N, Yoshimori T, Levine B . Methods in mammalian autophagy research. Cell 2010; 140: 313–326.

    Article  CAS  Google Scholar 

  10. Yang Z, Klionsky DJ . Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22: 124–131.

    Article  CAS  Google Scholar 

  11. McFarlane S, Aitken J, Sutherland JS, Nicholl MJ, Preston VG, Preston CM . Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J Virol 2011; 85: 4212–4221.

    Article  CAS  Google Scholar 

  12. Kondo Y, Kanzawa T, Sawaya R, Kondo S . The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726–734.

    Article  CAS  Google Scholar 

  13. Turcotte S, Giaccia AJ . Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol 2010; 22: 246–251.

    Article  CAS  Google Scholar 

  14. Lamkanfi M, Dixit VM . Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 2010; 8: 44–54.

    Article  CAS  Google Scholar 

  15. Guo ZS, Liu Z, Bartlett DL . Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity. Front Oncol 2014; 4: 74.

    PubMed  PubMed Central  Google Scholar 

  16. Orvedahl A, Alexander D, Tallóczy Z, Sun Q, Wei Y, Zhang W et al. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007; 1: 23–35.

    Article  CAS  Google Scholar 

  17. Schmid D, Münz C . Innate and adaptive immunity through autophagy. Immunity 2007; 27: 11–21.

    Article  CAS  Google Scholar 

  18. Kudchodkar SB, Levine B . Viruses and autophagy. Rev Med Virol 2009; 19: 359–378.

    Article  CAS  Google Scholar 

  19. Chou J, Kern ER, Whitley RJ, Roizman B . Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 1990; 250: 1262–1266.

    Article  CAS  Google Scholar 

  20. He B, Gross M, Roizman B . The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997; 94: 843–848.

    Article  CAS  Google Scholar 

  21. Tallóczy Z, Jiang W, Virgin HW 4th, Leib DA, Scheuner D, Kaufman RJ et al. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 2002; 99: 190–195.

    Article  Google Scholar 

  22. Tovilovic G, Ristic B, Siljic M, Nikolic V, Kravic-Stevovic T, Dulovic M et al. mTOR-independent autophagy counteracts apoptosis in herpes simplex virus type 1-infected U251 glioma cells. Microbes Infect 2013; 15: 615–624.

    Article  CAS  Google Scholar 

  23. Yordy B, Iwasaki A . Cell type-dependent requirement of autophagy in HSV-1 antiviral defense. Autophagy 2013; 9: 236–138.

    Article  CAS  Google Scholar 

  24. Petrovski G, Pasztor K, Orosz L, Albert R, Mencel E, Moe MC et al. Herpes simplex virus types 1 and 2 modulate autophagy in SIRC corneal cells. J Biosci 2014; 39: 683–692.

    Article  Google Scholar 

  25. Yakoub AM, Shukla D . Herpes simplex virus-1 fine-tunes host’s autophagic response to infection: a comprehensive analysis in productive infection models. PLoS ONE 2015; 10: e0124646.

    Article  Google Scholar 

  26. Yakoub AM, Shukla D . Autophagy stimulation abrogates herpes simplex virus-1 infection. Sci Rep 2015; 5: 9730.

    Article  CAS  Google Scholar 

  27. Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY et al. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res 1997; 57: 1502–1509.

    CAS  PubMed  Google Scholar 

  28. Liu BL, Robinson M, Han ZQ, Branston RH, English C, Reay P et al. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther 2003; 10: 292–303.

    Article  CAS  Google Scholar 

  29. Campadelli-Fiume G, De Giovanni C, Gatta V, Nanni P, Lollini PL, Menotti L . Rethinking herpes simplex virus: the way to oncolytic agents. Rev Med Virol 2011; 21: 213–226.

    Article  CAS  Google Scholar 

  30. Takaoka H, Takahashi G, Ogawa F, Imai T, Iwai S, Yura Y . A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma. Virol J 2011; 8: 294.

    Article  CAS  Google Scholar 

  31. Takahashi G, Meshii N, Hamada M, Iwai S, Yura Y . Sequence of a fusogenic herpes simplex virus, RH2, for oncolytic virotherapy. J Gen Virol 2013; 94: 726–737.

    Article  CAS  Google Scholar 

  32. Meshii N, Takahashi G, Okunaga S, Hamada M, Iwai S, Takasu A et al. Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus. Cancer Gene Ther 2013; 20: 493–498.

    Article  CAS  Google Scholar 

  33. Takasu A, Masui A, Hamada M, Imai T, Iwai S, Yura Y . Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells. Cancer Gene Ther 2016; 23: 107–113.

    Article  CAS  Google Scholar 

  34. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998; 72: 8586–8596.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6: 1221–1228.

    Article  CAS  Google Scholar 

  36. Benetti L, Munger J, Roizman B . The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol 2003; 77: 6567–6573.

    Article  CAS  Google Scholar 

  37. Kraft RM, Nguyen ML, Yang XH, Thor AD, Blaho JA . Caspase 3 activation during herpes simplex virus 1 infection. Virus Res 2006; 120: 163–175.

    Article  CAS  Google Scholar 

  38. Lotfi K, Zackrisson AL, Peterson C . Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance. Cancer Lett 2002; 178: 141–149.

    Article  CAS  Google Scholar 

  39. Colunga AG, Laing JM, Aurelian L . The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins. Gene Ther 2010; 17: 315–327.

    Article  CAS  Google Scholar 

  40. Farassati F, Yang AD, Lee PW . Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. Nat Cell Biol 2001; 3: 745–750.

    Article  CAS  Google Scholar 

  41. Smith KD, Mezhir JJ, Bickenbach K, Veerapong J, Charron J, Posner MC et al. Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol 2006; 80: 1110–1120.

    Article  CAS  Google Scholar 

  42. Alexander DE, Ward SL, Mizushima N, Levine B, Leib DA . Analysis of the role of autophagy in replication of herpes simplex virus in cell culture. J Virol 2007; 81: 12128–12134.

    Article  CAS  Google Scholar 

  43. Kanai R, Zaupa C, Sgubin D, Antoszczyk SJ, Martuza RL, Wakimoto H et al. Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors. J Virol 2012; 86: 4420–4431.

    Article  CAS  Google Scholar 

  44. Peri P, Nuutila K, Vuorinen T, Saukko P, Hukkanen V . Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells. J Gen Virol 2011; 92: 173–180.

    Article  CAS  Google Scholar 

  45. Guo H, Kaiser WJ, Mocarski ES . Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol 2015; 204: 439–448.

    Article  CAS  Google Scholar 

  46. Endo Y, Sakai R, Ouchi M, Onimatsu H, Hioki M, Kagawa S et al. Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation. Oncogene 2008; 27: 2375–2381.

    Article  CAS  Google Scholar 

  47. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, Thorburn A . Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 2009; 16: 175–183.

    Article  CAS  Google Scholar 

  48. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334: 1573–1577.

    Article  CAS  Google Scholar 

  49. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Müller M et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci USA 2005; 102: 7922–7927.

    Article  CAS  Google Scholar 

  50. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007; 26: 2527–2539.

    Article  CAS  Google Scholar 

  51. Scorrano L, Korsmeyer SJ . Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003; 304: 437–444.

    Article  CAS  Google Scholar 

  52. Jiang H, White EJ, Ríos-Vicil CI, Xu J, Gomez-Manzano C, Fueyo J . Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol 2011; 85: 4720–4729.

    Article  CAS  Google Scholar 

  53. Yokoyama T, Iwado E, Kondo Y, Aoki H, Hayashi Y, Georgescu MM et al. Autophagy-inducing agents augment the antitumor effect of telomerase-selective oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther 2008; 15: 1233–1239.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Shintaro Kira for his advice on flow cytometry. This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (No. 24390453).

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan

    Y Furukawa, A Takasu & Y Yura

Authors
  1. Y Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Takasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Yura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Yura.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furukawa, Y., Takasu, A. & Yura, Y. Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells. Cancer Gene Ther 24, 393–400 (2017). https://doi.org/10.1038/cgt.2017.33

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2017.33

This article is cited by

Search

Advanced search

Quick links